Literature DB >> 1511385

Conservative treatment of rectal cancer. Extending the indications.

R P Billingham1.   

Abstract

Rectal cancer often in the past was believed to require abdominoperineal resection with permanent colostomy to achieve a cure. Several surgical alternatives to colostomy currently are available for selected patients. Understanding of the methods of preoperative staging is increasing, and new techniques, such as intrarectal ultrasound, have provided improved accuracy. By applying this and other methods of preoperative staging, selection of a surgical approach appropriate to the tumor stage increasingly is possible. Curative treatment for rectal cancer often can be achieved while preserving anorectal function.

Entities:  

Mesh:

Year:  1992        PMID: 1511385     DOI: 10.1002/1097-0142(19920901)70:3+<1355::aid-cncr2820701525>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  Treatment of stage II-III rectal cancer patients.

Authors:  Miranda B Kim; Theodore S Hong; Jennifer Y Wo
Journal:  Curr Oncol Rep       Date:  2014       Impact factor: 5.075

2.  Transanal total mesorectal excision combined with intersphincteric resection has similar long-term oncological outcomes to laparoscopic abdominoperineal resection in low rectal cancer: a propensity score-matched cohort study.

Authors:  Zhi-Hang Liu; Zi-Wei Zeng; Hai-Qing Jie; Liang Huang; Shuang-Ling Luo; Wen-Feng Liang; Xing-Wei Zhang; Liang Kang
Journal:  Gastroenterol Rep (Oxf)       Date:  2022-06-14

3.  Long-Term Outcomes and Lymph Node Metastasis in Patients Receiving Radical Surgery for Pathological T1 Lower Rectal Cancer.

Authors:  Daichi Kitaguchi; Takeshi Sasaki; Yuji Nishizawa; Yuichiro Tsukada; Masaaki Ito
Journal:  World J Surg       Date:  2019-02       Impact factor: 3.352

Review 4.  Sphincter preservation in rectal cancer.

Authors:  C G Willett
Journal:  Curr Treat Options Oncol       Date:  2000-12

5.  Sphincter-sparing surgery after preoperative radiotherapy for low rectal cancers: feasibility, oncologic results and quality of life outcomes.

Authors:  A S Allal; S Bieri; A Pelloni; V Spataro; S Anchisi; P Ambrosetti; M A Sprangers; J M Kurtz; P Gertsch
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

6.  Postoperative Chemoradiotherapy After Local Resection for High-Risk T1 to T2 Low Rectal Cancer: Results of a Single-Arm, Multi-Institutional, Phase II Clinical Trial.

Authors:  Takeshi Sasaki; Yoshinori Ito; Masayuki Ohue; Yukihide Kanemitsu; Takaya Kobatake; Masaaki Ito; Yoshihiro Moriya; Norio Saito
Journal:  Dis Colon Rectum       Date:  2017-09       Impact factor: 4.585

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.